TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare
TG Therapeutics, Inc. Revenue 2016–2025
TG Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- TG Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 204.9 M, a 69.56% increase year-over-year.
- TG Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 628.6 M, a 62.59% increase year-over-year.
- TG Therapeutics, Inc. annual revenue for 2025 was 616.3 M, a 87.32% increase from 2024.
- TG Therapeutics, Inc. annual revenue for 2024 was 329.0 M, a 40.80% increase from 2023.
- TG Therapeutics, Inc. annual revenue for 2023 was 233.7 M, a 8290.02% increase from 2022.
- TG Therapeutics, Inc. annual revenue for 2022 was 2.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TG Therapeutics, Inc. Earnings — FAQ
TG Therapeutics, Inc. (TGTX) earnings over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TGTX's earnings history?
The chart and table above show TG Therapeutics, Inc.'s earnings by year and by quarter, including the growth rate.